This website collects cookies to deliver better user experience. Cookie Policy
Accept
Sign In
The Wall Street Publication
  • Home
  • Trending
  • U.S
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
    • Markets
    • Personal Finance
  • Tech
  • Lifestyle
    • Lifestyle
    • Style
    • Arts
  • Health
  • Sports
  • Entertainment
Reading: CDC Backs Pfizer-BioNTech Booster for Immunocompromised Children
Share
The Wall Street PublicationThe Wall Street Publication
Font ResizerAa
Search
  • Home
  • Trending
  • U.S
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
    • Markets
    • Personal Finance
  • Tech
  • Lifestyle
    • Lifestyle
    • Style
    • Arts
  • Health
  • Sports
  • Entertainment
Have an existing account? Sign In
Follow US
© 2024 The Wall Street Publication. All Rights Reserved.
The Wall Street Publication > Blog > Business > CDC Backs Pfizer-BioNTech Booster for Immunocompromised Children
Business

CDC Backs Pfizer-BioNTech Booster for Immunocompromised Children

Editorial Board Published January 4, 2022
Share
CDC Backs Pfizer-BioNTech Booster for Immunocompromised Children
SHARE

The Pfizer-BioNTech Covid-19 vaccine is the only one authorized for people under 18 years.

Photo: Maddie McGarvey for The Wall Street Journal

By

Felicia Schwartz

Jan. 4, 2022 11:36 am ET

The Centers for Disease Control and Prevention recommended that many children with weakened immune systems get a booster from Pfizer Inc. PFE -3.74% and BioNTech SE BNTX -3.35% four weeks after their second shot.

The agency issued the recommendation Tuesday for moderately and severely immunocompromised children 5 to 11 years.

It also said that people who received the vaccine from Pfizer and partner BioNTech should receive a booster dose five months after their second shot, shortening the timeline by a month.

The recommendations “ensure that the most vulnerable children can get an additional dose to optimize protection against Covid-19,” said CDC director Rochelle Walensky.

The decisions follow the Food and Drug Administration’s authorization of both measures on Monday.

The FDA also cleared boosters for 12- to 15-year-olds, but the CDC is waiting to issue a recommendation until its advisory panel meets Wednesday to discuss expanding the shots to adolescents.

Many states and vaccination sites follow the recommendations of the CDC before giving the shots.

To bolster people’s protection against the Omicron variant, health authorities have been urging people to get an extra dose, and a growing number of institutions and businesses are mandating boosters.

Early research indicates the additional doses are needed to protect against Omicron.

To help combat Omicron, the Biden administration is opening up more Covid testing sites and delivering 500 million Covid tests to Americans. WSJ’s Daniela Hernandez breaks down why testing is still a pain point in the U.S., two years into the pandemic. Photo Illustration: David Fang

Fully vaccinated children between 5 and 11 years who aren’t immunocompromised don’t currently need boosters, the FDA said. It said it is reviewing additional data related to younger children and Covid-19.

The Pfizer-BioNTech Covid-19 vaccine is the only one authorized for people under 18 years, while shots from Moderna Inc. and Johnson & Johnson are cleared for those 18 and over.

The CDC’s recent booster moves don’t affect people who got the Moderna or Johnson & Johnson vaccines.

Under the CDC’s recommendations, people who took the Moderna vaccine should get a booster six months after their second dose, while Johnson & Johnson vaccine recipients should receive any booster dose two months after their initial dose.

The CDC has previously backed mixing and matching primary vaccine doses and boosters. Immunocompromised people ages 12 years and older had also been cleared to receive booster doses after one month.

Write to Felicia Schwartz at [email protected]

Covid-19 Vaccines

Copyright ©2022 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Appeared in the January 5, 2022, print edition as ‘CDC Backs Booster For At-Risk Children.’

Contents
The Pfizer-BioNTech Covid-19 vaccine is the only one authorized for people under 18 years.Felicia SchwartzCovid-19 Vaccines
TAGGED:Business NewsPAIDWall Street Publication
Share This Article
Twitter Email Copy Link Print
Previous Article Investors, Here’s How to Brace for the Year of Central Bank Divergence Investors, Here’s How to Brace for the Year of Central Bank Divergence
Next Article GOP lawmakers urge Supreme Court to strike down Biden’s workplace vaccine-or-test order GOP lawmakers urge Supreme Court to strike down Biden’s workplace vaccine-or-test order

Editor's Pick

Bay Space lawmaker pushes to require AI firms to launch security insurance policies

Bay Space lawmaker pushes to require AI firms to launch security insurance policies

By Shirin Ghaffary, Bloomberg State Senator Scott Wiener, a San Francisco Democrat, has launched a invoice that may require firms…

By Editorial Board 3 Min Read
You Don’t Want an iPad, however Do You Need One? Then These Prime Day Apple Offers Are for You
You Don’t Want an iPad, however Do You Need One? Then These Prime Day Apple Offers Are for You

When you've got one Apple product, you normally have all of them—whether…

15 Min Read
San Jose: After 18 years, Siena Bistro is right down to its closing days
San Jose: After 18 years, Siena Bistro is right down to its closing days

Longtime clients have been packing Siena Bistro for its closing days and…

5 Min Read

Oponion

STAZ SHIFT — NFT & METAVERSE ARTIST

STAZ SHIFT — NFT & METAVERSE ARTIST

ANASTASIYA GILEVICH (STAZ SHIFT) — mixed and Spain based virtual reality…

June 16, 2022

Microsoft Prepares to Go to Battle With FTC Over Activision Deal

TechSoftware company says deal won’t threaten…

December 17, 2022

15 Greatest Beard Trimmers for 2025 | Fashion

We independently consider all really helpful…

May 5, 2025

Lyft Lays Off About 60 Employees, Folds Its Car Rentals for Riders

Lyft Inc. has shed about 60…

July 20, 2022

rSIM launches in North America at Cellular World Congress Las Vegas 2024

rSIM, the world’s first actually resilient…

October 8, 2024

You Might Also Like

Thales Reinforces its Management in eSIM and IoT Connectivity with a ‘Ready to Use’ Licensed Resolution
Business

Thales Reinforces its Management in eSIM and IoT Connectivity with a ‘Ready to Use’ Licensed Resolution

At a time when billions of linked objects are reshaping industries, Thales has achieved a vital safety certification for its…

4 Min Read
Soracom IoT Platform Achieves SOC 2 Kind 2 Compliance for Safety, Availability, and Confidentiality
Business

Soracom IoT Platform Achieves SOC 2 Kind 2 Compliance for Safety, Availability, and Confidentiality

Soracom, Inc., right now introduced that it has efficiently achieved System and Group Controls (SOC) 2 Kind 2 compliance, reinforcing…

2 Min Read
Mobile IoT Module Shipments Grew 23% in Q1 2025 as US–China tensions affect vendor panorama
Business

Mobile IoT Module Shipments Grew 23% in Q1 2025 as US–China tensions affect vendor panorama

In brief Shipments of mobile IoT modules and chipsets grew 23% year-over-year in Q1 2025, based on IoT Analytics’ International…

20 Min Read
Prime 7 Visitor Posting Marketplaces to Purchase Visitor Posts That Drive Search engine optimization Outcomes
Business

Prime 7 Visitor Posting Marketplaces to Purchase Visitor Posts That Drive Search engine optimization Outcomes

Utilizing a visitor posting market helps you overlook all that like a nasty nightmare. However how do you discover probably…

14 Min Read
The Wall Street Publication

About Us

The Wall Street Publication, a distinguished part of the Enspirers News Group, stands as a beacon of excellence in journalism. Committed to delivering unfiltered global news, we pride ourselves on our trusted coverage of Politics, Business, Technology, and more.

Company

  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • WP Creative Group
  • Accessibility Statement

Contact

  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability

Term of Use

  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices

© 2024 The Wall Street Publication. All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?